Suchergebnisse - "Pariente, Benjamin"

PubPharm (8)

1

Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis : A GETAID cohort

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Uzzan, M. | Bresteau, C. | Laharie, D. | +49

CommentIn: Aliment Pharmacol Ther. 2021 Aug;54(3):341-342. - PMID 34236096

2

Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Bossuyt, P. | Dreesen, E. | Rimola, J. | +31

3

Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease : A Post Hoc Analysis of TAILORIX

enthalten in: The American journal of gastroenterology | 2021

von Rivière, P. | D'Haens, G. | Peyrin-Biroulet, L. | +8

4

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Dreesen, E. | Baert, F. | Laharie, D. | +12

CommentIn: Clin Gastroenterol Hepatol. 2020 Jan;18(1):262. - PMID 31220636

5

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Pineton de Chambrun, G. | Amiot, A. | Bouguen, G. | +33

6

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease

enthalten in: Gastroenterology | 2018

von D'Haens, G. | Vermeire, S. | Lambrecht, G. | +27

CommentIn: Gastroenterology. 2018 Oct;155(4):1277-1278. - PMID 30222942

7

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

enthalten in: Inflammatory bowel diseases | 2017

von Guerbau, L. | Gerard, R. | Duveau, N. | +11

8

Costs of Crohn's Disease According to Severity States in France : A Prospective Observational Study and Statistical Modeling over 10 Years

enthalten in: Inflammatory bowel diseases | 2016

von Boschetti, G. | Nancey, S. | Daniel, F. | +12

1
[1]